UNSPSC 51111744: Galarubicin

This classification denotes an anthracycline antibiotic with the molecular formula C30H32FNO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6F39648E92, chemically known as (8s,10s)-10-((2.6-dideoxy-2-fluoro-alpha-l-talopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 8(2)-ester with beta-alanine. but generally known as galarubicin, which bears US NIH Compound Identifier 219086.

UNSPSC 51111744 Galarubicin is a Commodity code that captures pharmaceutical products procured through state and local health agencies, though recent activity shows state and local governments buying under this code tag include antibiotics, opioid-reversal agents, and related public-health pharmaceuticals rather than galarubicin specifically. State health departments and county public-health authorities are the primary issuing bodies, often leveraging cooperative purchasing vehicles such as MMCAP Infuse and similar consortia to aggregate demand and secure multi-year supply agreements at volume pricing. Work solicited under the code centers on bulk pharmaceutical supply contracts with quarterly or annual delivery schedules to public-health facilities, fixed-price bidding structures, and compliance requirements including drug-free workplace certification and E-Verify eligibility verification.

Recent activity is concentrated in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for a total of $2.99 million over three years (12-month initial term plus two renewal options) covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets supplied to state stockpiles. Seminole County, Florida issued an IFB in June 2026 seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building; the contract carried an initial two-year term with one-year renewal option and included potential FEMA funding with associated federal compliance requirements. Both procurements used competitive IFB processes and included all-inclusive delivery-cost pricing and multi-year or renewable terms typical of state and local pharmaceutical supply chains.